37 results
8-K
EX-10.1
AUPH
Aurinia Pharmaceuticals Inc
21 Sep 23
Aurinia Board of Directors Appoints Dr. Robert T. Foster as New Board Director
4:06pm
of or economic exposure to any Voting Securities or engage in any swap or hedging transaction, or other derivative agreement of any nature with respect … to sell, directly or indirectly, through swap or hedging transactions or otherwise, all or substantially all, voting rights decoupled from
DEF 14A
eh8fw5w
10 May 21
Definitive proxy
4:06pm
PRE 14A
a8tx56dmq34q
27 Apr 21
Preliminary proxy
4:32pm
10-K
rj7 la1it4m0
24 Feb 21
Annual report
4:09pm
SUPPL
ofw0t
23 Jul 20
Supplemental materials (foreign)
4:06pm
SUPPL
3kn3y1i5stod lwg
26 Jun 20
Supplemental materials (foreign)
4:08pm
F-10/A
bto58lbfifw
17 Jun 20
Registration of securities (Canada) (amended)
4:35pm
F-10
dytmq8j8ka5uvf
29 May 20
Registration of securities (Canada)
4:07pm
6-K
EX-99.3
g0du y1k426el1
28 Apr 20
Notice of Annual General and Special Meeting of Shareholders
4:30pm
SUPPL
hxprwo
10 Dec 19
Supplemental materials (foreign)
4:31pm
SUPPL
9k3t6gx0bybr l6os9o
9 Dec 19
Supplemental materials (foreign)
6:35am
SUPPL
qdy0n18wx8
13 Sep 19
Supplemental materials (foreign)
5:05pm
6-K
EX-99.2
llgbeg8z
31 May 19
Notice of Annual General Meeting of Shareholders
8:26am
40-F
EX-99.2
c1bvuxl8
19 Mar 19
Annual report (Canada)
4:16pm
40-F
EX-99.3
s28g6m210 pte
19 Mar 19
Annual report (Canada)
4:16pm